✦ LIBER ✦

Docetaxel (TaxotereTM), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study

✍ Scribed by Sternberg, CN; Ten Bokkel Huinink, WW; Smyth, JF; Bruntsch, V; Dirix, LY; Pavlidis, NA; Franklin, H; Wanders, S; Le Bail, N; Kaye, SB

Book ID: 109837017
Publisher: Nature Publishing Group
Year: 1994
Tongue: English
Weight: 698 KB
Volume: 70
Category: Article
ISSN: 0007-0920
DOI: 10.1038/bjc.1994.309

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel (TaxotereTM) in advanced gastr

Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

✍ Sulkes, A; Smyth, J; Sessa, C; Dirix, LY; Vermorken, JB; Kaye, S; Wanders, J; Fr 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 745 KB

A phase III trial of 5-fluorouracil and

A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study

✍ Michael J. O'Connell 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 498 KB 👁 2 views

The Mayo Clinic and the North Central Cancer Treatment Group (NCCTG) conducted a randomized clinical trial comparing five different combination chemotherapeutic regimens to single-agent 5-fluorouracil (5-FU), given by intravenous bolus technique (500 mg/m2 for 5 days) as a control, in the treatment

Carzelesin phase II study in advanced br

Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)

✍ Nicholas Pavlidis; Steinar Aamdal; Ahmad Awada; Hilary Calvert; Pierre Fumoleau; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 80 KB